Analysis of TCGA data from glioma patients treated with TMZ (Figure 1A) revealed that the expression of spermine synthase (SMS) was significantly higher in patients with progressive disease (PD) compared to those with a complete response (CR), partial response (PR), or stable disease (SD). This evidence concerns the gene SMS and central nervous system cancer.